Newtyn Management, LLC historic quarter change: USA Other Stocks, Sold out
In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 23 quarters from 2013-06-30 to 2026-06-30, Newtyn Management, LLC opened 34 positions, added to 32, reduced 28 and sold out of 46.
- Q2 2026: Stock ENVIRI CORP; Country of operation United States; Class COM; Shares before 5,502,200.
- Q1 2026: Stock INDIVIOR PLC; Country of operation —; Class ORD; Shares before 2,534,538.
- Q3 2025: Stock SAGE THERAPEUTICS INC; Country of operation United States; Class COM; Shares before 700,000.
- Q2 2025: Stock 2SEVENTY BIO INC; Country of operation United States; Class COMMON STOCK; Shares before 2,534,836.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1569241), 23 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-15); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-17); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2012-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q2 2026 | ENVIRI CORP
CUSIP 415864107 | United States | COM | 5,502,200 | 0 | -5,502,200 | $107,953,164 | $0 | -$107,953,164 | 2026-08-14 |
|---|
| Q1 2026 | INDIVIOR PLC
CUSIP G4766E116 | | ORD | 2,534,538 | 0 | -2,534,538 | $90,939,223 | $0 | -$90,939,223 | 2026-05-15 |
|---|
| Q3 2025 | SAGE THERAPEUTICS INC
CUSIP 78667J108 | United States | COM | 700,000 | 0 | -700,000 | $6,384,000 | $0 | -$6,384,000 | 2025-11-14 |
|---|
| Q2 2025 | 2SEVENTY BIO INC
CUSIP 901384107 | United States | COMMON STOCK | 2,534,836 | 0 | -2,534,836 | $12,522,090 | $0 | -$12,522,090 | 2025-08-14 |
|---|
| Q2 2025 | THIRD HARMONIC BIO INC
CUSIP 88427A107 | United States | COM | 635,150 | 0 | -635,150 | $2,203,970 | $0 | -$2,203,970 | 2025-08-14 |
|---|
| Q1 2025 | INFLECTION PT ACQUISITN CRP
CUSIP G4790U102 | | CL A ORD SHS | 700,000 | 0 | -700,000 | $8,036,000 | $0 | -$8,036,000 | 2025-05-15 |
|---|
| Q1 2025 | REVANCE THERAPEUTICS INC
CUSIP 761330109 | United States | COM | 1,810,000 | 0 | -1,810,000 | $5,502,400 | $0 | -$5,502,400 | 2025-05-15 |
|---|
| Q4 2024 | ENDEAVOR GROUP HLDGS INC
CUSIP 29260Y109 | United States | CL A COM | 1,124,234 | 0 | -1,124,234 | $32,108,123 | $0 | -$32,108,123 | 2025-02-14 |
|---|
| Q4 2024 | GLATFELTER CORPORATION
CUSIP 377320106 | United States | COM | 889,759 | 0 | -889,759 | $1,601,566 | $0 | -$1,601,566 | 2025-02-14 |
|---|
| Q4 2024 | BOLT BIOTHERAPEUTICS INC
CUSIP 097702104 | United States | COM | 468,910 | 0 | -468,910 | $303,854 | $0 | -$303,854 | 2025-02-14 |
|---|
| Q3 2024 | ALIGOS THERAPEUTICS INC
CUSIP 01626L105 | United States | COM | 719,287 | 0 | -719,287 | $251,750 | $0 | -$251,750 | 2024-11-14 |
|---|
| Q2 2024 | MERRIMACK PHARMACEUTICALS IN
CUSIP 590328209 | United States | COM NEW | 1,873,694 | 0 | -1,873,694 | $27,674,460 | $0 | -$27,674,460 | 2024-08-14 |
|---|
| Q2 2024 | AVID BIOSERVICES INC
CUSIP 05368M106 | United States | COM | 1,500,000 | 0 | -1,500,000 | $10,050,000 | $0 | -$10,050,000 | 2024-08-14 |
|---|
| Q2 2024 | AVROBIO INC
CUSIP 05455M100 | United States | COM | 1,118,892 | 0 | -1,118,892 | $1,432,182 | $0 | -$1,432,182 | 2024-08-14 |
|---|
| Q2 2024 | SENSEI BIOTHERAPEUTICS INC
CUSIP 81728A108 | United States | COM | 930,230 | 0 | -930,230 | $976,741 | $0 | -$976,741 | 2024-08-14 |
|---|
| Q1 2024 | CYTEIR THERAPEUTICS INC
CUSIP 23284P103 | United States | COM | 3,021,500 | 0 | -3,021,500 | $9,185,360 | $0 | -$9,185,360 | 2024-05-15 |
|---|
| Q1 2024 | HOMOLOGY MEDICINES INC
CUSIP 438083107 | United States | COM | 1,399,260 | 0 | -1,399,260 | $850,750 | $0 | -$850,750 | 2024-05-15 |
|---|
| Q1 2024 | ADVERUM BIOTECHNOLOGIES INC
CUSIP 00773U108 | | COM | 823,096 | 0 | -823,096 | $619,627 | $0 | -$619,627 | 2024-05-15 |
|---|
| Q1 2024 | ARCA BIOPHARMA INC
CUSIP 00211Y506 | United States | COM | 269,320 | 0 | -269,320 | $457,844 | $0 | -$457,844 | 2024-05-15 |
|---|
| Q1 2024 | NUKKLEUS INC
CUSIP 67054R104 | United States | COM | 26,990 | 0 | -26,990 | $76,921 | $0 | -$76,921 | 2024-05-15 |
|---|
| Q3 2016 | HERTZ GLOBAL HOLDINGS INC
CUSIP 42805T105 | | COM | 24,794 | 0 | -24,794 | $853,000 | $0 | -$853,000 | 2016-11-15 |
|---|
| Q2 2016 | FOREST CITY ENTERPRISES INC
CUSIP 345550107 | | CL A | 5,000,000 | 0 | -5,000,000 | $105,450,000 | $0 | -$105,450,000 | 2016-08-15 |
|---|
| Q2 2016 | KLX INC
CUSIP 482539103 | | COM | 808,100 | 0 | -808,100 | $25,972,000 | $0 | -$25,972,000 | 2016-08-15 |
|---|
| Q2 2016 | ALLERGAN PLC
CUSIP G0177J108 | | SHS | 90,500 | 0 | -90,500 | $24,257,000 | $0 | -$24,257,000 | 2016-08-15 |
|---|
| Q2 2016 | AVANGRID INC
CUSIP 05351W103 | United States | COM | 470,000 | 0 | -470,000 | $18,852,000 | $0 | -$18,852,000 | 2016-08-15 |
|---|
| Q2 2016 | OCWEN FINL CORP
CUSIP 675746309 | | COM NEW | 2,000,000 | 0 | -2,000,000 | $4,940,000 | $0 | -$4,940,000 | 2016-08-15 |
|---|
| Q2 2016 | NUVECTRA CORP
CUSIP 67075N108 | | COM | 58,100 | 0 | -58,100 | $314,000 | $0 | -$314,000 | 2016-08-15 |
|---|
| Q1 2016 | INTERXION HOLDING N.V
CUSIP N47279109 | | SHS | 650,000 | 0 | -650,000 | $19,598,000 | $0 | -$19,598,000 | 2016-05-16 |
|---|
| Q4 2015 | STATE NATL COS INC
CUSIP 85711T305 | | COM | 1,470,000 | 0 | -1,470,000 | $13,745,000 | $0 | -$13,745,000 | 2016-02-16 |
|---|
| Q3 2015 | HUDSON CITY BANCORP
CUSIP 443683107 | | COM | 5,072,754 | 0 | -5,072,754 | $50,119,000 | $0 | -$50,119,000 | 2015-11-16 |
|---|
| Q3 2015 | MODUSLINK GLOBAL SOLUTIONS I
CUSIP 60786L206 | | COM NEW | 210,000 | 0 | -210,000 | $714,000 | $0 | -$714,000 | 2015-11-16 |
|---|
| Q2 2015 | STARWOOD WAYPOINT RESIDENTL
CUSIP 85571W109 | | COM SHS | 959,816 | 0 | -959,816 | $24,811,000 | $0 | -$24,811,000 | 2015-08-14 |
|---|
| Q2 2015 | KLX INC
CUSIP 482539103 | | COM | 94,500 | 0 | -94,500 | $3,642,000 | $0 | -$3,642,000 | 2015-08-14 |
|---|
| Q1 2015 | COVIDIEN PLC
CUSIP G2554F113 | | SHS | 395,000 | 0 | -395,000 | $40,401,000 | $0 | -$40,401,000 | 2015-05-15 |
|---|
| Q1 2015 | MODUSLINK GLOBAL SOLUTIONS I
CUSIP 60786L107 | | COM | 1,725,000 | 0 | -1,725,000 | $6,469,000 | $0 | -$6,469,000 | 2015-05-15 |
|---|
| Q4 2014 | LEUCADIA NATL CORP
CUSIP 527288104 | | COM | 51,100 | 0 | -51,100 | $1,218,000 | $0 | -$1,218,000 | 2015-02-17 |
|---|
| Q3 2014 | DSW INC
CUSIP 23334L102 | | CL A | 400,000 | 0 | -400,000 | $11,176,000 | $0 | -$11,176,000 | 2014-11-14 |
|---|
| Q3 2014 | QLT INC
CUSIP 746927102 | | COM | 364,200 | 0 | -364,200 | $2,251,000 | $0 | -$2,251,000 | 2014-11-14 |
|---|
| Q2 2014 | CST BRANDS INC
CUSIP 12646R105 | | COM | 825,000 | 0 | -825,000 | $25,773,000 | $0 | -$25,773,000 | 2014-08-14 |
|---|
| Q4 2013 | WASHINGTON POST CO
CUSIP 939640108 | | CL B | 35,922 | 0 | -35,922 | $21,961,000 | $0 | -$21,961,000 | 2014-02-14 |
|---|
| Q4 2013 | GYRODYNE CO AMER INC
CUSIP 403820103 | | COM | 110,000 | 0 | -110,000 | $8,239,000 | $0 | -$8,239,000 | 2014-02-14 |
|---|
| Q4 2013 | KEARNY FINL CORP
CUSIP 487169104 | | COM | 533,000 | 0 | -533,000 | $5,447,000 | $0 | -$5,447,000 | 2014-02-14 |
|---|
| Q3 2013 | ASSISTED LIVING CONCPT NEV N
CUSIP 04544X300 | | CL A NEW | 1,325,000 | 0 | -1,325,000 | $15,847,000 | $0 | -$15,847,000 | 2013-11-14 |
|---|
| Q3 2013 | ENGILITY HLDGS INC
CUSIP 29285W104 | | COM | 275,000 | 0 | -275,000 | $7,815,000 | $0 | -$7,815,000 | 2013-11-14 |
|---|
| Q3 2013 | E TRADE FINANCIAL CORP
CUSIP 269246401 | | COM NEW | 350,000 | 0 | -350,000 | $4,431,000 | $0 | -$4,431,000 | 2013-11-14 |
|---|
| Q3 2013 | MAXYGEN INC
CUSIP 577776107 | | COM | 835,736 | 0 | -835,736 | $2,073,000 | $0 | -$2,073,000 | 2013-11-14 |
|---|